Literature DB >> 18677714

Validation of an item bank for detecting and assessing psychological distress in cancer patients.

Adam B Smith1, Robert Rush, Penny Wright, Dan Stark, Galina Velikova, Michael Sharpe.   

Abstract

OBJECTIVE: To validate an item bank for assessing and detecting psychological distress in cancer patients by (1) identifying whether additional items are required in the full item bank; (2) identifying any item bias in the existing item bank; (3) linking levels of distress against thresholds derived from gold-standard psychiatric interviews (PSE/SCAN/SCID).
METHOD: A Rasch analysis was conducted on a heterogeneous sample of cancer patients (n=4919) who had completed a combination of eight psychological distress screening instruments. A subset of patients had completed a psychiatric interview along with the HADS (n=381) or PHQ-9 (n=440). Item thresholds were plotted along the latent trait. Furthermore, items were assessed for differential item functioning (DIF) by age and gender. Finally, optimum thresholds were derived for the HADS and PHQ-9 and plotted along the latent trait distribution for the entire item bank. RESULT: Item thresholds exceeded the range of person measures, although a gap was still present along the latent trait. No DIF was observed for either age or gender. Putative cut-offs were derived for the item bank detecting moderate to severe levels of psychological distress.
CONCLUSION: The item bank covers the majority of levels of emotional distress reported by cancer patients. Additionally, initial thresholds have been derived on the item bank, which correspond to a formal psychiatric assessment. Further work is required to ascertain the stability of the item bank over time and by diagnosis and stage of disease, as well as to determine additional thresholds for levels of distress. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 18677714     DOI: 10.1002/pon.1423

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  7 in total

1.  Cross-cultural validity of the Spanish version of PHQ-9 among pregnant Peruvian women: a Rasch item response theory analysis.

Authors:  Qiuyue Zhong; Bizu Gelaye; Jesse R Fann; Sixto E Sanchez; Michelle A Williams
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

Review 2.  Modifying measures based on differential item functioning (DIF) impact analyses.

Authors:  Jeanne A Teresi; Mildred Ramirez; Richard N Jones; Seung Choi; Paul K Crane
Journal:  J Aging Health       Date:  2012-03-15

3.  Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.

Authors:  Erin E Hahn; Corrine E Munoz-Plaza; Dana Pounds; Lindsay Joe Lyons; Janet S Lee; Ernest Shen; Benjamin D Hong; Shannon La Cava; Farah M Brasfield; Lara N Durna; Karen W Kwan; David B Beard; Alexander Ferreira; Aswini Padmanabhan; Michael K Gould
Journal:  JAMA       Date:  2022-01-04       Impact factor: 157.335

4.  Validity of the Patient Health Questionnaire-9 for depression screening and diagnosis in East Africa.

Authors:  Bizu Gelaye; Michelle A Williams; Seblewengel Lemma; Negussie Deyessa; Yonas Bahretibeb; Teshome Shibre; Dawit Wondimagegn; Asnake Lemenhe; Jesse R Fann; Ann Vander Stoep; Xiao-Hua Andrew Zhou
Journal:  Psychiatry Res       Date:  2013-08-22       Impact factor: 3.222

5.  Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.

Authors:  Monika K Krzyzanowska; Jim A Julian; Melanie Powis; Doris Howell; Craig C Earle; Katherine A Enright; Nicole Mittmann; Maureen E Trudeau; Eva Grunfeld
Journal:  BMC Cancer       Date:  2019-09-05       Impact factor: 4.430

6.  Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.

Authors:  Monika K Krzyzanowska; Jim A Julian; Chu-Shu Gu; Melanie Powis; Qing Li; Katherine Enright; Doris Howell; Craig C Earle; Sonal Gandhi; Sara Rask; Christine Brezden-Masley; Susan Dent; Leena Hajra; Orit Freeman; Silvana Spadafora; Caroline Hamm; Nadia Califaretti; Maureen Trudeau; Mark N Levine; Eitan Amir; Louise Bordeleau; James A Chiarotto; Christine Elser; Juhi Husain; Nicole Laferriere; Yasmin Rahim; Andrew G Robinson; Ted Vandenberg; Eva Grunfeld
Journal:  BMJ       Date:  2021-12-08

7.  Screening for depression in primary care: a Rasch analysis of the PHQ-9.

Authors:  Mike Horton; Amanda E Perry
Journal:  BJPsych Bull       Date:  2016-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.